유바이오로직스

206650KOSDAQ의약품 제조업

64.8 / 100

Reference Date: 2026-07-24

Financial Score24.5 / 40

News Sentiment21.3 / 25

Momentum5.0 / 20

Disclosure14.0 / 15

AI Analysis: ROE significantly exceeds the industry average but PBR raises overvaluation concerns. Declined 10.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

YuBioLogics, established in 2010, is a biotech company specializing in vaccine development and supply, as well as CRMO services. It supplies cholera vaccines to UNICEF, achieving sales of 65.4 billion KRW in 2023, with continued growth driven by increasing global cholera outbreaks. The company aims to expand its product line to include typhoid and meningitis vaccines, targeting global market leadership.

Number of Employees

397people

Average Salary

60.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

7.00Industry Average 11.236.5Point

Lower than industry avg (good)

PBR

1.65Industry Average 0.810.0Point

2.0x industry avg (risky)

ROE

26.85Industry Average 4.017.0Point

6.7x industry avg (excellent)

Debt Ratio

13.20Industry Average 12.432.0Point

Higher than industry avg (caution)

Trend 2023~20259.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲46.9% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲211.3% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 9.7% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Positive
유바이오로직스, 콜레라 넘어 장티푸스·수막구균…종합 백신기업 속...
유바이오로직스가 콜레라 백신 성공을 바탕으로 장티푸스와 수막구균 백신 개발로 다품종 백신 기업으로 성장하는 전략 발표로 긍정적 평가.
Positive
유바이오로직스, 콩고에 경구용 콜레라 백신 101억원 규모 공급
유바이오로직스가 콩고에 경구용 콜레라 백신을 대규모 공급함으로써 국제적인 보건 기여를 인정받아 긍정적인 시장 반응을 기대할 수 있다.
Positive
유바이오로직스, 유니세프와 101억 규모 경구용 콜레라 백신 납품 계...
유바이오로직스가 유니세프와 대규모 경구용 콜레라 백신 납품 계약을 체결하여 매출 증대 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (3%, downtrend)

Current 7,890Won52-week high 16,20052-week low 7,600

1-month return1.0Point

1m -10.44% (falling)

Volume trend3.0Point

Volume flat

Detailed Disclosure

5 totalPositive 2Neutral 3Negative 0

Positive[기재정정]단일판매ㆍ공급계약체결(자율공시)2026-07-16
Positive단일판매ㆍ공급계약체결(자율공시)2026-07-14
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-06
Neutral신탁계약에의한취득상황보고서2026-07-02
Neutral기업설명회(IR)개최2026-06-30